Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB26FJRWX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,245
Award facts
- Contract value 100% obligated
- $3,244.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On October 28, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,244.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order, issued without set-aside designation, covers the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a specialty pharmaceutical product, with an ultimate completion date of October 29, 2025. DMS Pharmaceutical Group Inc. serves as the sole prime contractor on this award with no identified subcontractors.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply comprehensive pharmaceutical and medical consumable products to Department of Defense healthcare facilities worldwide. The parent IDC, valued at $499 million with a completion date of December 31, 2036, establishes DMS Pharmaceutical Group as a critical regional prime vendor contractor capable of fulfilling diverse pharmaceutical requirements across the military medical system. The company's extensive product portfolio and demonstrated performance across multiple therapeutic categories position it to support recurring medical supply needs for federal military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FJRWX?
SPE2DB26FJRWX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FJRWX worth?
The government has obligated $3,245 on SPE2DB26FJRWX.
Is contract SPE2DB26FJRWX an order under another contract?
Yes. SPE2DB26FJRWX is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWX competed?
The extent of competition for SPE2DB26FJRWX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award